Health Care: Drugs

Cardiome Pharma Corp (CRME: NASDAQ)

$4.13 -0.01 | -0.24%
05/25/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 25.26M 20.91M 30.04M 4.51M
Cost of Sales 6.06M 6.06M 9.80M 936.00K
Gross Operating Profit 19.20M 14.85M 20.24M 3.58M
Selling, General, and Administrative Expenses 30.51M 31.00M 33.81M 16.45M
Research & Development 0.00 3.22M 637.00K 476.00K
Operating Income before D & A (EBITDA) -11.32M -19.38M -14.21M -13.35M
Depreciation & Amortization 3.23M 2.70M 2.37M 649.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -2.37M -132.00K -110.00K 20.16M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -16.92M -22.21M -16.70M 4.96M
Interest Expense 2.54M 2.26M 1.48M 87.00K
Pre-Tax Income -19.47M -24.47M -18.18M 4.88M
Income Taxes 152.00K -11.00K 49.00K 102.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -19.62M -24.46M -18.23M 4.77M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -19.62M -24.46M -18.23M 4.77M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -19.62M -24.46M -18.23M 4.77M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-19.62M -24.46M -18.23M 5.98M
Preferred Dividends
Net Income Available To Common -19.62M -24.46M -18.23M 4.77M
Basic EPS from Continuing Ops. -0.78 -1.34 -1.12 0.37
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.78 -1.34 -1.12 0.37
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.78 -1.34 -1.12 0.37
Basic Normalized Net Income/Share -0.78 -1.34 -1.12 0.46
EPS fr Continuing Ops. -0.79 -1.34 -1.12 0.37
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.79 -1.34 -1.12 0.37
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.79 -1.34 -1.12 0.37
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.79 -1.34 -1.12 0.46
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CRME

Latest CRME Headlines from TheStreet

More Financial News for CRME

Press Releases for CRME

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter